Literature DB >> 16416695

Surveillance programs for chronic viral hepatitis in three health departments.

Douglas T Fleming1, Amy Zambrowski, Felicia Fong, Andrea Lombard, Lynne Mercedes, Claudia Miller, Jan Poujade, Aaron Roome, Amy Sullivan, Lyn Finelli.   

Abstract

Although chronic hepatitis B and chronic hepatitis C are diseases of public health importance, only a few health departments nationally have chronic viral hepatitis under surveillance; these programs rely primarily on direct reporting by medical laboratories. We conducted an evaluation to determine if lessons from these programs can guide other health departments. Between December 2002 and February 2003, we visited the Connecticut Department of Public Health, the Multnomah County Health Department in Portland, Oregon, and the Minnesota Department of Health to determine the capacity of their chronic hepatitis registries to monitor trends and provide case management. We found that the registries facilitated investigations of potentially acute cases by identifying previously known infections, and aided prevention planning by pinpointing areas where viral hepatitis was being diagnosed. For chronic cases, case management (defined as the process of ensuring that infected individuals and their partners receive medical evaluation, counseling, vaccination, and referral to specialists for treatment when indicated) was provided for hepatitis B in Multnomah County, but was limited in other programs; barriers included resource constraints, difficulties confirming chronic infection, and privacy concerns. Finding innovative ways to overcome these barriers and improve case management is important if chronic hepatitis surveillance is to realize its full potential.

Entities:  

Mesh:

Year:  2006        PMID: 16416695      PMCID: PMC1497804          DOI: 10.1177/003335490612100108

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  9 in total

1.  Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group.

Authors:  R R German; L M Lee; J M Horan; R L Milstein; C A Pertowski; M N Waller
Journal:  MMWR Recomm Rep       Date:  2001-07-27

2.  The prevalence of hepatitis C virus infection in the United States, 1988 through 1994.

Authors:  M J Alter; D Kruszon-Moran; O V Nainan; G M McQuillan; F Gao; L A Moyer; R A Kaslow; H S Margolis
Journal:  N Engl J Med       Date:  1999-08-19       Impact factor: 91.245

3.  Risk factors for acute non-A, non-B hepatitis in the United States and association with hepatitis C virus infection.

Authors:  M J Alter; S C Hadler; F N Judson; A Mares; W J Alexander; P Y Hu; J K Miller; L A Moyer; H A Fields; D W Bradley
Journal:  JAMA       Date:  1990-11-07       Impact factor: 56.272

4.  Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. Centers for Disease Control and Prevention.

Authors:  Miriam J Alter; Wendi L Kuhnert; Lyn Finelli
Journal:  MMWR Recomm Rep       Date:  2003-02-07

5.  Incidence and risk factors for acute hepatitis B in the United States, 1982-1998: implications for vaccination programs.

Authors:  Susan T Goldstein; Miriam J Alter; Ian T Williams; Linda A Moyer; Franklyn N Judson; Karen Mottram; Michael Fleenor; Patricia L Ryder; Harold S Margolis
Journal:  J Infect Dis       Date:  2002-02-28       Impact factor: 5.226

6.  Prevalence of hepatitis B virus infection in the United States: the National Health and Nutrition Examination Surveys, 1976 through 1994.

Authors:  G M McQuillan; P J Coleman; D Kruszon-Moran; L A Moyer; S B Lambert; H S Margolis
Journal:  Am J Public Health       Date:  1999-01       Impact factor: 9.308

7.  Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. Centers for Disease Control and Prevention.

Authors: 
Journal:  MMWR Recomm Rep       Date:  1998-10-16

8.  Incidence of hepatitis B virus infection in the United States, 1976-1994: estimates from the National Health and Nutrition Examination Surveys.

Authors:  P J Coleman; G M McQuillan; L A Moyer; S B Lambert; H S Margolis
Journal:  J Infect Dis       Date:  1998-10       Impact factor: 5.226

9.  Hepatitis B vaccination--United States, 1982-2002.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2002-06-28       Impact factor: 17.586

  9 in total
  5 in total

1.  Hepatitis B prevention and control: Lessons from the East and the West.

Authors:  Monica C Robotin
Journal:  World J Hepatol       Date:  2011-02-27

2.  Enhancing surveillance for hepatitis C through public health informatics.

Authors:  Dawn M Heisey-Grove; Daniel R Church; Gillian A Haney; Alfred Demaria
Journal:  Public Health Rep       Date:  2011 Jan-Feb       Impact factor: 2.792

3.  Pathology Laboratory Surveillance in the Australian Collaboration for Coordinated Enhanced Sentinel Surveillance of Sexually Transmitted Infections and Blood-Borne Viruses: Protocol for a Cohort Study.

Authors:  Caroline van Gemert; Rebecca Guy; Mark Stoove; Wayne Dimech; Carol El-Hayek; Jason Asselin; Clarissa Moreira; Long Nguyen; Denton Callander; Douglas Boyle; Basil Donovan; Margaret Hellard
Journal:  JMIR Res Protoc       Date:  2019-08-08

4.  Completeness of reporting of chronic hepatitis B and C virus infections--Michigan, 1995-2008.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-02-15       Impact factor: 17.586

5.  Hepatitis C Screening Among Medicaid Patients With Schizophrenia, 2002-2012.

Authors:  Marilyn D Thomas; Eric Vittinghoff; Stephen Crystal; James Walkup; Mark Olfson; Mandana Khalili; Priya Dahiya; Walker Keenan; Francine Cournos; Christina Mangurian
Journal:  Schizophr Bull Open       Date:  2022-01-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.